Clear Street LLC Immix Biopharma, Inc. Transaction History
Clear Street LLC
- $7 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding IMMX
# of Institutions
36Shares Held
5.09MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD1.56MShares$3.08 Million1.92% of portfolio
-
Bleichroeder LP New York, NY850KShares$1.68 Million0.81% of portfolio
-
Cable Car Capital LLC San Francisco, CA670KShares$1.33 Million2.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA456KShares$903,2480.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$801,90011.13% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $27.5M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...